# Routine PCI bij TAVI verhoogt bloedingen zonder overlevingsvoordeel

*geplaatst 2026-11-18 · Algemeen · Cardiology in review · doi 10.1097/CRD.0000000000001535 · https://hartvaat.nl/2026/11/10/routine-pci-bij-tavi-verhoogt-bloedingen-zonder-overlevingsvoordeel/*

Een meta-analyse van drie RCT’s (1156 patiënten) vergeleek routine PCI met conservatief beleid bij patiënten die een TAVI ondergaan. Routine PCI leidde niet tot minder sterfte, myocardinfarcten of beroertes, maar verhoogde wel het risico op ernstige bloedingen (RR 1,57) en willekeurige bloedingen (RR 1,77). Hoewel herinterventies minder vaak voorkwamen, pleiten de bevindingen voor een individuele, Heart Team-gestuurde afweging in plaats van routinematige PCI.

## English: Routine Percutaneous Coronary Intervention Versus Conservative Management in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

A meta-analysis of three randomized controlled trials (1,156 patients) compared routine PCI versus conservative management in patients undergoing transcatheter aortic valve implantation (TAVI). Routine PCI did not reduce all-cause mortality, cardiac death, myocardial infarction, or stroke, but significantly increased major bleeding (RR 1.57) and any bleeding (RR 1.77). While urgent revascularization was reduced, the findings support an individualized, heart Team-guided approach rather than routine PCI.

## Abstract (original, from the publication)

Coronary artery disease commonly coexists with severe aortic stenosis in transcatheter aortic valve implantation (TAVI) candidates, yet optimal revascularization remains debated. We meta-analyzed randomized controlled trials comparing routine percutaneous coronary intervention (PCI) before or concomitant with TAVI versus conservative management. Major databases were searched through May 2026. Random-effects models calculated risk ratios (RRs) with 95% confidence intervals (CIs), and evidence certainty was evaluated via the Grading of Recommendations Assessment, Development and Evaluation. Three randomized controlled trials (1156 patients; PCI: n = 579, conservative: n = 577) were included. Routine PCI was not associated with significant reductions in all-cause mortality (RR, 0.90; 95% CI, 0.70-1.15; P = 0.40), cardiac death (RR, 0.74; 95% CI, 0.51-1.08; P = 0.12), myocardial infarction (RR, 0.86; 95% CI, 0.45-1.64; P = 0.64), stroke (RR, 0.70; 95% CI, 0.48-1.03; P = 0.07), or hospitalization (RR, 1.07; 95% CI, 0.87-1.32; P = 0.52). However, PCI significantly increased major bleeding (RR, 1.57; 95% CI, 1.06-2.34; P = 0.02) and any bleeding (RR, 1.77; 95% CI, 1.27-2.48; P = 0.0008), while reducing urgent and repeat revascularization. In conclusion, routine PCI before or concomitant with TAVI reduces subsequent revascularization without conferring survival or ischemic benefit, while increasing bleeding complications. Given the moderate-to-low certainty of evidence, limited cumulative sample size, and clinical heterogeneity across trials, these findings warrant cautious interpretation and favor an individualized, Heart Team-guided revascularization strategy over routine PCI.

Auteurs: Ahmed Adel Mohamed, Bandar Alawlaqi, Abdullah Moemen Ahmed, Ahmed Elhadi, Ali Samir Galal, Eslam Saber Mahmoud, Ibrahim Saeed Shahda, Habiba Mostafa, Kenzy Ahmed Mohammed, Yousef Abdul-Rafea Saad, Hamzah M Alghzawi

---
Bron: Cardiology in review, https://doi.org/10.1097/CRD.0000000000001535. Bijgewerkt 2026-11-11T02:46:17Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.
